Evolent Health (EVH) Capital Expenditures (2015 - 2026)

Evolent Health has reported Capital Expenditures for 12 years, with the latest figure at $6.8 million in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 21.9% year-over-year to $6.8 million in Q2 2026; TTM through Jun 2026 was $30.0 million, a 0.58% increase from a year earlier, with the FY2025 full-year figure at $34.1 million, up 36.94% from the prior year.
• Capital Expenditures was $6.8 million for Q2 2026 at Evolent Health, up from $6.4 million in the prior quarter.
• The five-year high for Capital Expenditures was $10.7 million in Q4 2022, with the low at $5.3 million in Q1 2024.
• Average Capital Expenditures over 5 years is $7.7 million, with a median of $7.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 65.79% in 2022, then sank 43.67% in 2023.
• Over 5 years, Capital Expenditures stood at $10.7 million in 2022, then tumbled by 43.67% to $6.1 million in 2023, then increased by 1.64% to $6.2 million in 2024, then grew by 26.17% to $7.8 million in 2025, then declined by 11.75% to $6.8 million in 2026.
• The last three Capital Expenditures figures came in at $6.8 million (Q2 2026), $6.4 million (Q1 2026), and $7.8 million (Q4 2025), per Business Quant data.